Compare SKT & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKT | PBH |
|---|---|---|
| Founded | 1981 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.3B |
| IPO Year | 1994 | 2004 |
| Metric | SKT | PBH |
|---|---|---|
| Price | $36.01 | $67.14 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 4 |
| Target Price | $37.29 | ★ $80.75 |
| AVG Volume (30 Days) | ★ 1.0M | 392.4K |
| Earning Date | 05-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.18% | N/A |
| EPS Growth | N/A | ★ 2.88 |
| EPS | 0.71 | ★ 2.78 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.17 | $2.15 |
| P/E Ratio | $51.86 | ★ $24.57 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $28.69 | $57.25 |
| 52 Week High | $37.95 | $90.04 |
| Indicator | SKT | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 55.81 | 49.12 |
| Support Level | $31.76 | $60.75 |
| Resistance Level | $37.95 | $68.51 |
| Average True Range (ATR) | 0.80 | 1.80 |
| MACD | 0.05 | -0.24 |
| Stochastic Oscillator | 50.51 | 27.93 |
Tanger Inc is an owners and operators of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers, with a total gross leasable area of approximately 13.0 million square feet.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.